You are here

Fasenra

AstraZeneca Expands Fasenra’s Label to Younger Children with Severe Asthma

BioSpace

Fri, 04/12/24 - 11:15 am

eosinophilic asthma

AstraZeneca, working to grow Fasenra’s reach, touts positive trial against GSK's Nucala in new use

Fierce Pharma

Tue, 09/12/23 - 07:10 pm

clinical trials

eosinophilic asthma

AstraZeneca’s Fasenra meets primary endpoint in Phase III rare vasculitis trial

Clinical Trials Arena

Tue, 09/12/23 - 10:37 am

eosinophilic granulomatosis with polyangiitis

clinical trials

Weak data for Fasenra undermine AZ’s ambitions for the drug

Pharmaphorum

Tue, 10/25/22 - 10:35 am

eosinophilic asthma

chronic rhinosinusitis with nasal polyps

eosinophilic esophagitis

AstraZeneca debuts annoying purple ‘Phil’ creatures, personified asthma eosinophils ‘behaving badly’

Endpoints

Wed, 10/5/22 - 10:35 am

pharma marketing

DTC advertising

eosinophilic asthma

FDA says no to AZ’s Fasenra for nasal polyp indication

Pharmaforum

Mon, 03/14/22 - 10:19 am

AstraZeneca's Fasenra spares asthma patients from steroid use in large trial

Fierce Pharma

Thu, 10/29/20 - 12:10 pm

clinical trials

AstraZeneca's asthma drug succeeds late-stage study

Reuters

Thu, 09/10/20 - 10:35 am

clinical trials

FDA green lights AstraZeneca's asthma drug Fasenra for self-administration

Yahoo/Reuters

Fri, 10/4/19 - 10:25 am

AstraZeneca’s Fasenra gets FDA ODD status for eosinophilic oesophagitis

Pharmaceutical Business Review

Thu, 08/29/19 - 10:28 am

eosinophilic esophagitis

AstraZeneca respiratory business gets boost from 3-drug inhaler results

Yahoo/Reuters

Wed, 08/28/19 - 10:52 am

AstraZeneca's Fasenra offers severe asthma patients 2 years of benefits: analysis

Fierce Pharma

Mon, 05/20/19 - 10:12 am

clinical trials

AstraZeneca’s asthma drug Fasenra looks promising for a set of rare chronic immune diseases

Endpoints

Thu, 04/4/19 - 10:30 am

Astrazeneca's Fasenra Gets Orphan Drug Designation for Autoimmune Disease

Yahoo/Zacks.com

Tue, 11/27/18 - 12:09 pm

eosinophilic granulomatosis with polyangiitis

AstraZeneca, shut out of COPD, touts long-term Fasenra asthma data

Fierce Pharma

Tue, 09/18/18 - 10:13 pm

NICE says yes to AstraZeneca’s Fasenra, but only when its GSK rival can’t be used

Fierce Pharma

Sun, 07/22/18 - 12:21 pm

AstraZeneca drug Fasenra fails to achieve main goal in COPD trial

Yahoo/Reuters

Wed, 05/30/18 - 10:21 am

clinical trials

AstraZeneca's Fasenra (benralizumab) Fails Ph III Trial for COPD

CP Wire

Fri, 05/11/18 - 10:03 am

AstraZeneca's Fasenra (benralizumab) Fails Ph III Trial for COPD

Fri, 05/11/18 - 10:01 am

Drugmakers take to Japan: 3 new drug approvals won by AstraZeneca, Merck, and EA Pharma

Endpoints

Sat, 01/20/18 - 02:56 pm

Pages